Mayda F. Gursel

Balcova, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Clinical Features, Treatment Outcomes, and Cytokine Levels in Pediatric Tularemia Patients in Türkiye.

Clinical Features, Treatment Outcomes, and Cytokine Levels in Pediatric Tularemia Patients in Türkiye.

Journal: The American journal of tropical medicine and hygiene

Published: February 18, 2026

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C.

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C.

Journal: The Journal of allergy and clinical immunology

Published: October 03, 2025

Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency.

Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency.

Journal: The Journal of allergy and clinical immunology

Published: June 04, 2025

Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis.

Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis.

Journal: Journal of extracellular vesicles

Published: April 05, 2025

Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides.

Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides.

Journal: Journal of autoimmunity

Published: February 14, 2025

In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis.

In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis.

Journal: PLoS neglected tropical diseases

Published: January 20, 2025

A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine.

A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine.

Journal: Vaccine

Published: September 29, 2024

Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.

Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.

Journal: The Journal of allergy and clinical immunology

Published: September 22, 2024

Diagnostic challenges in cutaneous leishmaniasis due to atypical Leishmania infantum: pathologists' insights from re-emergence zones.

Diagnostic challenges in cutaneous leishmaniasis due to atypical Leishmania infantum: pathologists' insights from re-emergence zones.

Journal: Frontiers in medicine

Published: June 22, 2024

Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesicles.

Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesicles.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 02, 2024

Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccine.

Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccine.

Journal: International immunology

Published: February 05, 2024

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.

Journal: Frontiers in immunology

Published: January 21, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026